{"transactions":[{"id":778831,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-14T21:02:42.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the 2019 Plan) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control."}],"balance_after":37500,"derivative":{"exercise_price":6.04,"expiration_date":"2036-05-12","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001243399-26-000001","document":"form4-05142026_090538.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000124339926000001/form4-05142026_090538.xml","form_type":"4"}},{"id":778830,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-14T21:02:42.000Z","date":"2026-05-12","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan (the \"2019 Plan\")) through the vesting date. In the event of a Change in Control (as defined in the 2019 Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such Change in Control."}],"balance_after":32366,"source":{"system":"sec-edgar","filing":"0001243399-26-000001","document":"form4-05142026_090538.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000124339926000001/form4-05142026_090538.xml","form_type":"4"}},{"id":1140254,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-20T20:12:06.000Z","date":"2025-05-16","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control."}],"balance_after":50000,"derivative":{"exercise_price":4.95,"expiration_date":"2035-05-16","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-013791","document":"form4-05202025_080503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000141588925013791/form4-05202025_080503.xml","form_type":"4"}},{"id":1506955,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-22T01:31:20.000Z","date":"2024-05-17","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control."}],"balance_after":50000,"derivative":{"exercise_price":1.4,"expiration_date":"2034-05-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-24-014046","document":"form4-05222024_010511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000141588924014046/form4-05222024_010511.xml","form_type":"4"}},{"id":1595043,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-05T22:15:53.000Z","date":"2024-03-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.67,"value":16700.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.65 to $1.67. The price reported above reflects the weighted average price. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":26116,"source":{"system":"sec-edgar","filing":"0001415889-24-006773","document":"form4-03052024_100343.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000141588924006773/form4-03052024_100343.xml","form_type":"4"}},{"id":1738841,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-11-16T21:14:15.000Z","date":"2023-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":23122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 28, 2023, Mallinckrodt plc (the \"Company\") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the \"Irish High Court\") seeking the appointment of an examiner (the \"Examiner\") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the \"Plan\"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the \"Scheme\"). On November 14, 2023 (the \"Effective Date\"), the Plan and the Scheme became effective and the Company emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of the Company's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. In connection with emergence, the reporting person ceased to be a Section 16 reporting person. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-119115","document":"tm2330745-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000110465923119115/tm2330745-10_4seq1.xml","form_type":"4"}},{"id":1841918,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-29T22:52:57.000Z","date":"2023-06-16","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26277,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The restricted stock units (the \"RSUs\") granted to the reporting person on January 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors (the \"Board\") of Mallinckrodt's approval of changes to the compensation of non-employee members of the Board (such changes, the \"Compensation Changes\"). In connection with the Compensation Changes, and in consideration of the cancelation of the RSUs, the reporting person will receive (i) in the event of a bankruptcy filing, additional cash compensation for 2023 of $210,000 or (ii) in the absence of a bankruptcy filing, additional cash compensation for 2023 of $245,000. In either event, the amounts are to be prepaid pro rata on a quarterly basis and paid in arrears for the prior quarters of fiscal year 2023."}],"balance_after":23122,"source":{"system":"sec-edgar","filing":"0001104659-23-076472","document":"tm2320181-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000110465923076472/tm2320181-4_4seq1.xml","form_type":"4"}},{"id":1841917,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-06-29T22:52:57.000Z","date":"2023-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3154,"price":1.28,"value":4037.12,"ownership":{"direct":true},"balance_after":49399,"source":{"system":"sec-edgar","filing":"0001104659-23-076472","document":"tm2320181-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000110465923076472/tm2320181-4_4seq1.xml","form_type":"4"}},{"id":1884310,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-20T00:45:39.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such Change in Control."}],"balance_after":40000,"derivative":{"exercise_price":2.07,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-031284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919123031284/doc4.xml","form_type":"4"}},{"id":2062119,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:03:58.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":26277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported ordinary shares represent restricted stock units (\"RSUs\"), which will be settled in an equal number of MNK ordinary shares and will vest ratably\non each of the first two anniversaries of MNK's emergence from Chapter 11 proceedings on June 16, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 26,277 newly awarded RSUs and\n26,276 RSUs previously reported in Table II."}],"balance_after":52553,"source":{"system":"sec-edgar","filing":"0001104659-23-001547","document":"tm231710-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000110465923001547/tm231710-8_4seq1.xml","form_type":"4"}},{"id":2159216,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-09-15T01:17:26.000Z","date":"2022-08-16","kind":"disposition_to_issuer","acquired":false,"shares":22533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"As previously disclosed, on August 16, 2022, Dr. Woodrow A. Myers, Jr. agreed to relinquish 22,533 of the restricted stock units (\"RSUs\") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the \"MIP\"). Mallinckrodt plc (\"Mallinckrodt\") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Dr. Myers 26,277 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As previously disclosed, on August 16, 2022, Dr. Woodrow A. Myers, Jr. agreed to relinquish 22,533 of the restricted stock units (\"RSUs\") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the \"MIP\"). Mallinckrodt plc (\"Mallinckrodt\") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Dr. Myers 26,277 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As previously disclosed, on August 16, 2022, Dr. Woodrow A. Myers, Jr. agreed to relinquish 22,533 of the restricted stock units (\"RSUs\") which were previously granted to him on July 1, 2022, with relinquishment to be applied ratably across both vesting tranches of such award, to remedy ministerial errors in computation and to correct for the fact that the RSU grant may have as a technical matter exceeded the applicable annual grant maximum amount set forth in the Mallinckrodt Pharmaceuticals 2022 Stock and Incentive Plan (the \"MIP\"). Mallinckrodt plc (\"Mallinckrodt\") has agreed that, as soon as reasonably practical following January 1, 2023, Mallinckrodt will grant to Dr. Myers 26,277 RSUs, subject to his continued service through such date and the MIP grant value limit, which will vest ratably on each of the first two anniversaries of emergence."}],"balance_after":26276,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22533},"source":{"system":"sec-edgar","filing":"0001104659-22-100152","document":"tm2225913-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000110465922100152/tm2225913-5_4seq1.xml","form_type":"4"}},{"id":2211602,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-07T01:14:48.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":48809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The grant of restricted stock units vests in equal installments on each of the first and second anniversaries of the date of Mallinckrodt plc's emergence from bankruptcy (June 16, 2022). Each restricted stock unit represents one Ordinary Share, and may be redeemed in either cash or stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The grant of restricted stock units vests in equal installments on each of the first and second anniversaries of the date of Mallinckrodt plc's emergence from bankruptcy (June 16, 2022). Each restricted stock unit represents one Ordinary Share, and may be redeemed in either cash or stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The grant of restricted stock units vests in equal installments on each of the first and second anniversaries of the date of Mallinckrodt plc's emergence from bankruptcy (June 16, 2022). Each restricted stock unit represents one Ordinary Share, and may be redeemed in either cash or stock."}],"balance_after":48809,"derivative":{"underlying":"Ordinary Shares","underlying_shares":48809},"source":{"system":"sec-edgar","filing":"0000899243-22-025537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000089924322025537/doc4.xml","form_type":"4"}},{"id":2263410,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-19T23:45:48.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":15035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control."}],"balance_after":15035,"derivative":{"exercise_price":4.81,"expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":15035},"source":{"system":"sec-edgar","filing":"0001209191-22-030775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919122030775/doc4.xml","form_type":"4"}},{"id":2263409,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-19T23:45:48.000Z","date":"2022-05-17","kind":"grant","acquired":true,"shares":10770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control."}],"balance_after":16116,"source":{"system":"sec-edgar","filing":"0001209191-22-030775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919122030775/doc4.xml","form_type":"4"}},{"id":2707594,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-18T20:28:38.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":4229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become immediately exercisable prior to the effectiveness of such change in control."}],"balance_after":4229,"derivative":{"exercise_price":19.74,"expiration_date":"2031-05-14","underlying":"Common Stock","underlying_shares":4229},"source":{"system":"sec-edgar","filing":"0001209191-21-033498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919121033498/doc4.xml","form_type":"4"}},{"id":2707593,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-18T20:28:38.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":2736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's\ncommon stock upon settlement. 100% of the shares subject to the RSU shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders. In the event of a change in control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the RSU shall vest immediately prior to the effectiveness of such change in control."}],"balance_after":5346,"source":{"system":"sec-edgar","filing":"0001209191-21-033498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919121033498/doc4.xml","form_type":"4"}},{"id":2802798,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-08T23:14:16.000Z","date":"2021-03-06","kind":"grant","acquired":true,"shares":3719,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 3 annual installments starting on March 6, 2022."}],"balance_after":3719,"derivative":{"exercise_price":23.99,"expiration_date":"2031-03-06","underlying":"Common Stock","underlying_shares":3719},"source":{"system":"sec-edgar","filing":"0001209191-21-018685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919121018685/doc4.xml","form_type":"4"}},{"id":2802797,"issuer":{"id":4572,"kind":"organization","name":"Personalis, Inc.","symbol":"PSNL"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-08T23:14:16.000Z","date":"2021-03-06","kind":"grant","acquired":true,"shares":2610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\").  Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement.  The RSUs vest in 3 annual installments with the first installment vesting on March 6, 2022."}],"balance_after":2610,"source":{"system":"sec-edgar","filing":"0001209191-21-018685","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000120919121018685/doc4.xml","form_type":"4"}},{"id":3721061,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T22:02:35.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":8006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":60.66,"expiration_date":"2027-05-11","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":8006},"source":{"system":"sec-edgar","filing":"0000950138-18-000693","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000693/edgar.xml","form_type":"4"}},{"id":3721060,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T22:02:35.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":7032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":72.74,"expiration_date":"2026-05-04","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":7032},"source":{"system":"sec-edgar","filing":"0000950138-18-000693","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000693/edgar.xml","form_type":"4"}},{"id":3721059,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T22:02:35.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":5604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":84.08,"expiration_date":"2025-05-06","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":5604},"source":{"system":"sec-edgar","filing":"0000950138-18-000693","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000693/edgar.xml","form_type":"4"}},{"id":3721058,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T22:02:35.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":6402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":67.05,"expiration_date":"2021-05-07","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":6402},"source":{"system":"sec-edgar","filing":"0000950138-18-000693","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000693/edgar.xml","form_type":"4"}},{"id":3721057,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2018-12-21T22:02:35.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":1872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted."}],"balance_after":0,"derivative":{"exercise_price":61.58,"expiration_date":"2020-05-09","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":1872},"source":{"system":"sec-edgar","filing":"0000950138-18-000693","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000693/edgar.xml","form_type":"4"}},{"id":3721056,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-21T22:02:35.000Z","date":"2018-12-20","kind":"disposition_to_issuer","acquired":false,"shares":14318,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the agreement and plan of merger (\"Merger Agreement\") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc., upon closing of the merger of Halfmoon II, Inc. with and into the Issuer (the \"Merger\"), each common share of the Issuer was converted into the right to receive 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 in cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950138-18-000693","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000693/edgar.xml","form_type":"4"}},{"id":3934503,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T22:06:29.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":2818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on May 1, 2019, May 1, 2020, and May 1, 2021."}],"balance_after":14318,"source":{"system":"sec-edgar","filing":"0000950138-18-000381","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013818000381/edgar.xml","form_type":"4"}},{"id":4211444,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-12T21:50:06.000Z","date":"2017-09-11","kind":"sale","acquired":false,"shares":3900,"price":63.934,"value":249342.6,"ownership":{"direct":true},"balance_after":11500,"source":{"system":"sec-edgar","filing":"0000950138-17-000625","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013817000625/edgar.xml","form_type":"4"}},{"id":4320597,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2017-05-15T21:11:50.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":8006,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of stock option pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Vests in three equal installments on May 1, 2018, May 1, 2019, and May 1, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock option pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Vests in three equal installments on May 1, 2018, May 1, 2019, and May 1, 2020."}],"balance_after":8006,"derivative":{"exercise_price":60.66,"expiration_date":"2027-05-11","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":8006},"source":{"system":"sec-edgar","filing":"0000950138-17-000435","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013817000435/edgar.xml","form_type":"4"}},{"id":4320596,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-15T21:11:50.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":1648,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Grant of restricted stock units pursuant to Express Scripts Holding Company 2016 Long-Term Incentive Plan. Awards vest in three equal installments on May 1, 2018, May 1, 2019, and May 1, 2020."}],"balance_after":15400,"source":{"system":"sec-edgar","filing":"0000950138-17-000435","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013817000435/edgar.xml","form_type":"4"}},{"id":4601377,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"exercise","acquired":false,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2011 Long-Term Incentive Plan. Vested in three (3) equal installments on May 1, 2014, May 1, 2015, and May 1, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2011 Long-Term Incentive Plan. Vested in three (3) equal installments on May 1, 2014, May 1, 2015, and May 1, 2016."}],"balance_after":1872,"derivative":{"exercise_price":61.58,"expiration_date":"2020-05-09","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}},{"id":4601376,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"exercise","acquired":false,"shares":6870,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2011 Long-Term Incentive Plan. Vested in three (3) equal installments on May 1, 2013, May 1, 2014, and May 1, 2015."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2011 Long-Term Incentive Plan. Vested in three (3) equal installments on May 1, 2013, May 1, 2014, and May 1, 2015."}],"balance_after":0,"derivative":{"exercise_price":52.53,"expiration_date":"2019-05-30","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":6870},"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}},{"id":4601375,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"exercise","acquired":false,"shares":1166,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2000 Long-Term Incentive Plan. Vested in three (3) equal installments on May 1, 2012, May 1, 2013, and May 1, 2014."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock options pursuant to the Express Scripts, Inc. 2000 Long-Term Incentive Plan. Vested in three (3) equal installments on May 1, 2012, May 1, 2013, and May 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":57.59,"expiration_date":"2018-05-04","underlying":"Express Scripts Holding Company Common Stock","underlying_shares":1166},"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}},{"id":4601374,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"sale","acquired":false,"shares":12036,"price":70.404,"value":847382.544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.39 to $70.406, inclusive. The Reporting Person undertakes to provide to Express Scripts Holding Company, any security holder of Express Scripts Holding Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":13752,"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}},{"id":4601373,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"exercise","acquired":true,"shares":4000,"price":61.58,"value":246320.0,"ownership":{"direct":true},"balance_after":25788,"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}},{"id":4601372,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"exercise","acquired":true,"shares":6870,"price":52.53,"value":360881.1,"ownership":{"direct":true},"balance_after":21788,"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}},{"id":4601371,"issuer":{"id":161583,"kind":"organization","name":"Express Scripts Holding Co.","symbol":"ESRX"},"owners":[{"id":47287,"kind":"person","name":"MYERS WOODROW A JR","position":1,"cik":"0001243399","reported_name":"MYERS WOODROW A JR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-16T20:47:20.000Z","date":"2016-09-14","kind":"exercise","acquired":true,"shares":1166,"price":57.59,"value":67149.94,"ownership":{"direct":true},"balance_after":14918,"source":{"system":"sec-edgar","filing":"0000950138-16-001317","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243399/000095013816001317/edgar.xml","form_type":"4"}}]}